An FDA-approved assay platform can detect biomarkers of neuronal and glial injury in the blood of COVID-19 patients
View ORCID ProfileAlexander V. Glushakov, Amy Y. Vittor, Lawrence Lewis, Stacey House, Maggie L. Bartlett, Olena Y. Glushakova, Dan Urbine, Darci R. Smith, Ronald L. Hayes
doi: https://doi.org/10.1101/2024.05.02.24306477
Alexander V. Glushakov
1Department of Surgery, Surgical Therapeutic Advancement Center, University of Virginia, Charlottesville, VA, USA
2Single Breath Inc., Dover, DE, USA
Amy Y. Vittor
3Department of Medicine and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Lawrence Lewis
4Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA
Stacey House
4Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA
Maggie L. Bartlett
5Parsons Corporation, Health and Biosciences, Centreville, VA
6Naval Medical Research Command, Biological Defense Research Directorate, Fort Detrick, MD, USA
Olena Y. Glushakova
7University of Virginia Cancer Center, Charlottesville, VA, USA
Dan Urbine
8Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, USA
Darci R. Smith
6Naval Medical Research Command, Biological Defense Research Directorate, Fort Detrick, MD, USA
Ronald L. Hayes
9Banyan Biomarkers, CA, USA
Data Availability
The assay results, patient clinical characteristics and selected unidentified demographic data are provided as supplemental materials.
Posted May 03, 2024.
An FDA-approved assay platform can detect biomarkers of neuronal and glial injury in the blood of COVID-19 patients
Alexander V. Glushakov, Amy Y. Vittor, Lawrence Lewis, Stacey House, Maggie L. Bartlett, Olena Y. Glushakova, Dan Urbine, Darci R. Smith, Ronald L. Hayes
medRxiv 2024.05.02.24306477; doi: https://doi.org/10.1101/2024.05.02.24306477
An FDA-approved assay platform can detect biomarkers of neuronal and glial injury in the blood of COVID-19 patients
Alexander V. Glushakov, Amy Y. Vittor, Lawrence Lewis, Stacey House, Maggie L. Bartlett, Olena Y. Glushakova, Dan Urbine, Darci R. Smith, Ronald L. Hayes
medRxiv 2024.05.02.24306477; doi: https://doi.org/10.1101/2024.05.02.24306477
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2771)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12423)
- Forensic Medicine (10)
- Gastroenterology (786)
- Genetic and Genomic Medicine (4288)
- Geriatric Medicine (396)
- Health Economics (703)
- Health Informatics (2769)
- Health Policy (1025)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4066)
- Nursing (218)
- Nutrition (602)
- Oncology (2145)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6671)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (171)